NEW CentoXome

Jorge serves as CENTOGENE’s Vice President Medical Genetics. Bringing in over 15 years of leadership experience, he is responsible for overseeing policies, management, and regulations to drive clinical and operational value. Before joining CENTOGENE, Jorge served as the Director of the Molecular Diagnostics and Genomics Labs at CGC Genetics. He holds a medical degree from the University of Porto and is specialized in Rare Disease Genetics, Neurogenetics, Dysmorphology, and Molecular Genetics.

Max has overall responsibility of driving CENTOGENE's Diagnostic business strategy and growth. He joins CENTOGENE from Roche Diagnostics, where he most recently served as Global Head of Medical Affairs of its Sequencing Business Unit. He came to Roche following the acquisition of Silicon Valley startup Ariosa Diagnostics Inc., where after a successful career in academic medicine, he helped build a leading global NIPT business. Prior to his medical career, Max worked as a Management Consultant for McKinsey & Company – developing and implementing strategies and solutions to overcome complex challenges in the pharmaceutical and biotechnology industry. Furthermore, he holds a medical degree from the University of Vienna and is board-certified with habilitation in Obstetrics and Gynecology and sub-specialty training in Maternal-Fetal Medicine, as well as certification in Clinical Genetics.